Biomimetic proteolipid vesicles for targeting inflamed tissues

R. Molinaro, C. Corbo, J. O. Martinez, F. Taraballi, M. Evangelopoulos, S. Minardi, I. K. Yazdi, P. Zhao, Enrica De Rosa, M. B. Sherman, A. de Vita, N. E. Toledano Furman, X. Wang, A. Parodi, E. Tasciotti

Research output: Contribution to journalArticlepeer-review

275 Scopus citations


A multitude of micro- and nanoparticles have been developed to improve the delivery of systemically administered pharmaceuticals, which are subject to a number of biological barriers that limit their optimal biodistribution. Bioinspired drug-delivery carriers formulated by bottom-up or top-down strategies have emerged as an alternative approach to evade the mononuclear phagocytic system and facilitate transport across the endothelial vessel wall. Here, we describe a method that leverages the advantages of bottom-up and top-down strategies to incorporate proteins derived from the leukocyte plasma membrane into lipid nanoparticles. The resulting proteolipid vesicles—which we refer to as leukosomes—retained the versatility and physicochemical properties typical of liposomal formulations, preferentially targeted inflamed vasculature, enabled the selective and effective delivery of dexamethasone to inflamed tissues, and reduced phlogosis in a localized model of inflammation.

Original languageEnglish (US)
Pages (from-to)1037-46
Number of pages10
JournalNature materials
Issue number9
StatePublished - Sep 2016

ASJC Scopus subject areas

  • Mechanical Engineering
  • Mechanics of Materials
  • Condensed Matter Physics
  • Materials Science(all)
  • Chemistry(all)


Dive into the research topics of 'Biomimetic proteolipid vesicles for targeting inflamed tissues'. Together they form a unique fingerprint.

Cite this